Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Oncol ; 63(3): 328-32, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8946867

ABSTRACT

CA 125 levels are often falsely elevated in disease-free endometrial cancer patients who have undergone abdominal radiation therapy. Because peritoneal irritation or mediators of inflammation can induce CA 125 production in mesothelium, the possibility that irradiated cultured mesothelial cells secrete CA 125 was investigated. Seven mesothelial cell isolates, an ovarian cell line which does not secrete CA 125, normal mammary epithelium, and normal fibroblasts were exposed to 500 cGy of 6-MV photon irradiation. Irradiated mesothelial cells showed little or no growth, while untreated cells increased in number. Twenty-four-hour CA 125 production was measured in the tissue culture medium on Day 4, and daily for one mesothelial cell isolate. Radiation stimulated CA 125 secretion in mesothelial cells up to 32 times over nonirradiated controls. The time course study showed that CA 125 levels increased rapidly in irradiated cells by Day 3 and remained elevated for the next 3 days. Increased immunoreactivity for p53 in irradiated mesothelial cells confirmed that a protein known to be radiation-inducible could be produced by the same conditions. Normal fibroblasts, mammary epithelium, and the ovarian cell line did not produce CA 125 in either the presence or absence of radiation. Thus, irradiated mesothelial cells are a potential source of serum CA 125 in patients who have received abdominal irradiation.


Subject(s)
CA-125 Antigen/metabolism , Endometrial Neoplasms/metabolism , Neoplasm Proteins/metabolism , Adult , Aged , Endometrial Neoplasms/radiotherapy , Epithelium/metabolism , Epithelium/radiation effects , Female , Humans , Middle Aged , Tumor Suppressor Protein p53/metabolism
2.
Gynecol Oncol ; 57(1): 109-12, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7705692

ABSTRACT

Two cases of recurrent noninvasive Paget's disease of the vulva in a split-thickness graft without an underlying adenocarcinoma are presented. This is the third report of recurrence of extramammary Paget's disease in a split-thickness graft, and the second of such an occurrence without an underlying dermal adnexa adenocarcinoma. A hypothesis for the possible pathogenetic mechanism of this unusual biological behavior is suggested.


Subject(s)
Neoplasm Recurrence, Local/etiology , Paget Disease, Extramammary/etiology , Skin Transplantation/pathology , Vulvar Neoplasms/etiology , Adenocarcinoma/diagnosis , Adenocarcinoma/etiology , Adenocarcinoma/pathology , Aged , Female , Humans , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/pathology , Paget Disease, Extramammary/pathology , Paget Disease, Extramammary/surgery , Skin Neoplasms/diagnosis , Skin Neoplasms/etiology , Skin Neoplasms/pathology , Vulvar Neoplasms/pathology , Vulvar Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...